ISSCR News


Madeline Lancaster Receives the 2021 Dr. Susan Lim Award for Outstanding Young Investigator
Press Release, Awards Keith Alm Press Release, Awards Keith Alm

Madeline Lancaster Receives the 2021 Dr. Susan Lim Award for Outstanding Young Investigator

Skokie, IL—The International Society for Stem Cell Research (ISSCR) will award the Dr. Susan Lim Award for Outstanding Young Investigator to Madeline Lancaster, PhD, The Medical Research Council (MRC) Laboratory of Molecular Biology, UK. The prize recognizes the exceptional achievements of an investigator in the early part of his or her independent career in stem cell research. Dr. Lancaster will present her science at a special lecture on 22 June at 1:15 p.m. EDT (13:15 EDT) during ISSCR 2021 Virtual, the world’s leading meeting of global innovators in stem cell science and regenerative medicine. The award is supported by the Dr. Susan Lim Endowment for Education and Research Ltd.

Read More
Valentina Greco Receives the 2021 ISSCR Momentum Award
Press Release, Awards Keith Alm Press Release, Awards Keith Alm

Valentina Greco Receives the 2021 ISSCR Momentum Award

Skokie, IL— The International Society for Stem Cell Research (ISSCR) will present this year’s ISSCR Momentum Award to Valentina Greco, PhD, Carolyn Walch Slayman Professor of Genetics at Yale School of Medicine and member of the Yale Stem Cell Center, USA.  The prize recognizes the exceptional achievements of an investigator whose innovative research has established a major area of stem cell-related research with a strong trajectory for future success. Dr. Greco will present her science during a special lecture on 25 June at 1:15 p.m. EDT (13:15 EDT) during ISSCR 2021 Virtual, the world’s leading meeting of global innovators in stem cell science and regenerative medicine.  

Read More
Press Release Keith Alm Press Release Keith Alm

The ISSCR’s VISION2030 Gathers Global Leaders in Stem Cell Research and Regenerative Medicine to Chart the Next Decade of Breakthroughs

Biotech business innovators and scientific trailblazers converge for a must attend future-forward event 7-8 January 2021

Skokie, IL – The ISSCR’s VISION2030: A Forecast for the Field is bringing together biotech CEOs who have successfully transformed scientific breakthroughs into thriving businesses that are improving human health. Join us for in-depth executive interviews that explore the next decade for the field on 7-8 January 2021. The event comes at a pivotal moment in regenerative medicine and stem cell science as discovery, translation, and investment intersect. Register and see the full program.

Read More
The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions
Press Release Keith Alm Press Release Keith Alm

The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions

12 August 2019 -- The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.

Read More
Hans Clevers Becomes President of the ISSCR
Press Release Keith Alm Press Release Keith Alm

Hans Clevers Becomes President of the ISSCR

The International Society for Stem Cell Research (ISSCR) is pleased to announce Hans Clevers, Hubrecht Institute, the Netherlands, as the incoming president of the ISSCR and its board of directors. Clevers assumes the post immediately following the 15th ISSCR Annual Meeting in Boston, 14-17 June, 2017.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .